• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.44% Nasdaq Down0.42%

    Valeant Pharmaceuticals International, Inc. (VRX)

    -NYSE
    197.39 Down 1.23(0.62%) Apr 1, 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Valeant Pharmaceuticals International, Inc.
    2150 St. Elz
    Laval, QC H7L 4A8
    Canada - Map
    Phone: 514-744-6792
    Fax: 514-744-6272
    Website: http://www.valeant.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Delivery
    Full Time Employees:16,800

    Business Summary 

    Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Solodyn to treat red and pus-filled pimples of acne in patients, as well as Ziana, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Wellbutrin XL for major depressive disorder in adults; Jublia for onychomycosis of the toenails; Xenazine for chorea; Targretin for Cutaneous T-Cell Lymphoma; Arestin, a subgingival sustained-release antibiotic; and PROVENGE for the treatment of prostate cancer. It also provides Zovirax, an antiviral for recurrent herpes labialis and initial genital herpes; Syprine to treat patients with Wilson's disease; Elidel to treat atopic dermatitis; Prolensa for inflammation and pain following cataract surgery; Duromine, a weight loss drug; and Lotemax gel for post-operative inflammation and pain. In addition, the company offers PreserVision, an antioxidant eye vitamin and mineral supplement; CeraVe to rebuild and repair the skin barrier; ReNu Multiplus to lubricate and rewet soft contact lenses; Biotrue for healthy contact lens wear; Ocuvite, a lutein eye vitamin and mineral supplement; Boston, a cleansing solution for gas permeable contact lenses; Artelac to treat dry eyes; AntiGrippin for acute respiratory and respiratory viral diseases, and influenza; and Bedoyecta, a vitamin B complex product. Further, it provides SofLens daily disposable contact lenses; PureVision, a contact lens; various ophthalmic surgical products; Biotrue ONEday lens; medical device systems for aesthetic applications; and Bausch + Lomb Ultra, a contact lens. Additionally, the company offers Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; Cardizem CD to treat hypertension and angina; and Latanoprost for the treatment of glaucoma. Valeant Pharmaceuticals International, Inc. was founded in 1983 and is headquartered in Laval, Canada.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Valeant Pharmaceuticals International, Inc.

    Corporate Governance 
    Valeant Pharmaceuticals International, Inc.’s ISS Governance QuickScore as of Mar 1, 2015 is 2. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 5; Compensation: 1.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. J. Michael Pearson , 56
    Chairman and Chief Exec. Officer
    7.00M0.00
    Mr. Howard Bradley Schiller , 53
    Chief Financial Officer, Principal Accounting Officer, Exec. VP and Director
    2.80M0.00
    Mr. Robert Roswell Chai-Onn , 45
    Chief Legal Officer, Head of Corp. & Bus. Devel., Exec. VP, Gen. Counsel and Corp. Sec.
    2.10M0.00
    Mr. Laizer D. Kornwasser , 44
    Exec. VP and Company Group Chairman
    1.24M0.00
    Mr. Christopher Bovaird , 55
    VP of Corp. Fin.
    N/AN/A
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders